Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

2(40.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 12 (40.0%)

N/A3 (60.0%)

Trials by Status

completed467%

recruiting117%

withdrawn117%

Recent Activity

1 active trials

Showing 5 of 6

recruiting

Clinical Trials (6)

Showing 6 of 6 trials

NCT05026554

Characterization of Chronic Hand Eczema

Recruiting

NCT06021405Not Applicable

Koebner's Phenomenon in Psoriasis and Lichen Planus

Withdrawn

NCT07179263Not Applicable

Inducing Redness Clinical Study

Completed

NCT02889159Phase 1

Immunologic Profile of Chronically Photodamaged Skin

Completed

NCT03876639Not Applicable

Topical Application of Highly Concentrated Water-in-oil Emulsions

Completed

NCT01628484Phase 1

Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation

Completed

All 6 trials loaded

Drug Details

Intervention Type: GENETIC
Total Trials: 6